O B J E C T I V E S This study hypothesized that 1 H magnetic resonance spectroscopy ( 1 H-MRS) can identify carotid plaque cholesteryl ester in vivo in humans.
C holesteryl ester in the liquid phase comprises a major portion of the lipid-rich core of atherosclerotic plaques, and its abundance has been associated with plaque rupture and formation of atherothrombosis (1) . The unique lipid composition of atheroma, with a high proportion of cholesteryl ester relative to other lipids, is mainly a result of the infiltration and retention of cholesterol carrying low-density lipoprotein that is transported through injured endothelium and penetrates the vascular tissue (2) . Furthermore, macrophages ingest and digest lipoprotein cholesterol and store it as cholesteryl ester in their cytoplasm as droplets (1) . Reversibility of atherosclerotic lesions is thought to be limited by removal of cholesteryl esters in the liquid phase, whereas dissolution of crystalline deposits are thought to be minimal (1) .
Quantification of liquid cholesteryl ester content of plaque is therefore valuable for the assessment of plaque vulnerability and for monitoring the effects of antiatherosclerotic drugs. However, techniques that permit this type of quantification on a molecular level in vivo in humans are currently not available. Imaging techniques such as ultrasound and magnetic resonance imaging (MRI) are quite capable of assessing plaque size (3) . In addition, MRI can identify plaque components, such as lipid-rich tissue, hemorrhage, and calcifications, through signal intensity differences elicited by varying contrastweighted sequences (3) . Nonetheless, the sensitivity of the detection of plaque cholesterol content is limited because lipid regions are inhomogeneous. Furthermore, lipid regions may contain crystals of cholesterol and are sometimes proximal to regions of calcification, both of which create a signal void in proton MRI. Image-guided proton 1 H magnetic resonance spectroscopy ( 1 H-MRS) has the potential to detect liquid cholesteryl ester noninvasively without the need for radiation or additional contrast agents (4) (5) (6) (7) . 1 H-MRS gives a spectrum of signals from all proton resonances in a given volume, thus affording detection of specific chemical components through their inherent frequency shift relative to water. On image-guided 1 H-MRS, a magnetic resonance image can be used to image and localize plaque. Proton spectra can then be collected from these plaques, so that the specific proton resonances of lipid components in a liquid state, including cholesteryl ester, can be identified (4-7). A major advantage is that a change in the composition of the plaque could be evaluated without (and potentially preceding) changes in plaque volume.
The aim of our study was to develop a noninvasive image-guided 1 H-MRS approach that enables quantification of plaque cholesteryl ester content. First, we assessed 1 H-MRS signals from lipid standards containing triglycerides and cholesteryl ester to characterize their spectrum. We then performed in vivo 1 H-MRS measurements of patients with atherosclerotic lesions in the carotid arteries.
M E T H O D S

Study design.
1 H-MRS spectra of pure cholesteryl ester and triglycerides as well as mixtures of both lipids were obtained. These data were acquired at Merck Research Laboratories, Rahway, New Jersey.
MRI (3.0-T) and 1 H-MRS of atherosclerotic plaques in carotid arteries of 35 patients were performed at the Academic Medical Center, Amsterdam, the Netherlands. The study protocol was reviewed and approved by the institutional review board, and all subjects gave written informed consent. Inclusion criteria were 18 to 75 years of age and carotid artery stenosis between 30% and 70% on duplex ultrasound. Exclusion criteria were previous or planned carotid surgery or any contraindication to MRI. The presence of cardiovascular risk factors and the use of medication were assessed by questionnaire. Brachial artery blood pressures were measured using an oscillometric blood pressure device (Omron 705IT, Omron Healthcare Inc., Lake Forest, Illinois). Weight and length were measured to calculate body mass index. Venous blood samples were obtained after overnight fasting to assess plasma total cholesterol, high-density lipoprotein cholesterol, and triglyceride levels. Low-density lipoprotein cholesterol levels were calculated using the Friedewald equation. In vivo carotid MRI and 1 H-MRS. MRI scans were performed using a 3.0-T whole-body scanner (3.0 Tesla Intera, Philips Medical Systems, Best, the Netherlands), using an 8-element carotid coil (Philips Medical Systems). For localization of the carotid plaques, axial T1-weighted image stacks were acquired at late diastole (retrospective electrocardiographic gating). Sequence parameters were turbo spin echo, double inversion recovery black blood prepulse, 2 signal averages, 8-ms TE, TR according to heart rate (w800 to 900 ms), 3-mm slice thickness, 240 matrix size, 60 Â 60-mm field of view, 0.25 Â 0.25-mm noninterpolated pixel size, and active fat suppression (spectral abiabatic inversion recovery). Acquisition time of the 1 H-MRS spectra was approximately 13 min, and total scan time including the T1-weighted imaging was w20 min.
MRI analysis was performed using semiautomated measurement software (VesselMass, Leiden University Medical Center, Leiden, the Netherlands). We drew the lumen and outer wall boundaries in the 2 slices (each with a 3-mm slice thickness) that were located where the 1 H-MRS voxel was located. The localization of the 1 H-MRS voxel was based on the axial T1-weighted image stacks, which enabled us to identify which T1-weighted slices were located in the 1 H-MRS voxel. We measured the lumen area (mm 2 ) and wall area (mm 2 ), which we multiplied by 5 mm (the slice thickness of the MRS voxel) to calculate lumen volume (mm 3 ) and wall volume (mm 3 ). Subsequently, perivascular tissue volume (mm 3 ) was calculated by subtracting the lumen volume and wall volume from the volume of the MRS voxel (which was 500 mm 3 ). After the 1 H-MRS scan was performed, we obtained another T1-weighted slice located in the 1 H-MRS voxel to assess whether the subject had moved during the 1 H-MRS scan.
Image-guided 1 H-MRS acquisition was performed on a 3.0-T whole-body scanner using an 8-element carotid coil (3.0 Tesla Intera, Philips Medical Systems). Spectra with and without water suppression were obtained. Two-dimensional chemical shift imaging data were collected using a point resolved spectroscopy sequence with the following parameters: TR H-magnetic resonance spectrum (right) of a carotid atherosclerotic plaque. The methylene (CH 2 ) peak and the allylic methylene (CH 2 -CH¼CH-CH 2 ) peak were fitted at 1.2 ppm and 2.0 ppm, respectively.
plaque were selected for further analysis (Fig. 1) . To minimize patient movement during the 1 H-MRS scan, we instructed the subjects not to move during the scan, and we reminded them of this by repeating this instruction just before starting the MRS sequence. The 4 voxels (total volume ¼ 500 mm 3 ) covering the carotid artery plaque that were selected for further analysis (Fig. 1) were processed using the freely available 3DiCSI package (version 1.9.11, Columbia University, New York, New York). Chemical shifts were reported using water as the internal standard at 4.65 ppm. Average spectra were then processed using specialized computer software (jMRUI 2.2, MRUI, Leuven, Belgium) (8) . Three peaks were line fitted: methyl (CH 3 ) at 0.8 ppm, methylene (CH 2 ) at 1.2 ppm, and allylic methylene (CH 2 -CH¼CH-CH 2 ) at 2.0 ppm (Fig. 1) . We used water-suppressed spectra to measure the 0.8-ppm, 1.2-ppm, and 2.0-ppm peaks. In a subset of 4 subjects, we performed initial and repeat 1 H-MRS scans with at least 1 week between scans to assess interscan reproducibility. Statistical analysis. Continuous variables are expressed as mean AE SD, unless otherwise specified. Spearman rho values were calculated to assess the correlation between the allylic methylene (2.0 ppm) to methylene (1.2 ppm) ratio and serum total cholesterol serum triglycerides, as well as the plaque volume to perivascular tissue volume ratio. Spearman rho was used because the data was not normally distributed. The agreement between initial and repeat 1 H-MRS scans within patients was assessed by the intraclass correlation coefficients (r), the SD of the paired differences, and the repeatability coefficient. All statistics were performed with SPSS version 19.0 (SPSS Inc., Chicago, Illinois).
R E S U L T S Lipid phantom results.
1 H-MRS spectra of lipid standards were obtained of 5 different mixtures of triglycerides and cholesteryl ester. The allylic methylene (CH 2 -CH¼CH-CH 2 at 2.0 ppm) to methylene (CH 2 at 1.2 ppm) ratio shows an increase as the amount of cholesteryl ester increases relative to triglycerides (Fig. 2) . Note that this increase remains present if the peaks of 2.0 ppm and 2.2 ppm are merged together as will be the case at lower field strength at lower spectral resolution. The absolute values of the 2.0 ppm to 1.2 ppm ratio of the lipid phantoms cannot be compared with the absolute values of the in vivo 2.0 ppm to 1.2 ppm ratio because different TEs were used in vivo and ex vivo and pure glyceryl trioleate and cholesteryl linoleate were used, whereas, in vivo, a mixture of different fatty acid chains exists. 2 ppm) , and allylic methylene (2.0 ppm) peaks were line fitted. The methyl (0.8 ppm) peak proved to be intricate to fit properly. Because of the limited spectral resolution the methyl peak (0.8 ppm) often partially blended into the methylene (1.2 ppm) peak and because of this, these fits were unreliable. Of the allylic methylene (2.0 ppm) and methylene (1.2 ppm) peaks, we were able to obtain good quality fits in 17 of 35 spectra. The median allylic methylene (2.0 ppm) to methylene (1.2 ppm) ratio was 0.10 (interquartile range: 0.08 to 0.12). In the plot on the right, the merged values of the peaks of 2.0 ppm and 2.2 ppm are used to calculate the 2.0:1.2 ppm ratio as will be the case at lower field strength at lower spectral resolution. CE ¼ cholesteryl ester; TG ¼ triglycerides.
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The volume of tissue from which we obtained the spectra was composed of blood in the lumen, plaque, and perivascular tissue. We assessed whether serum lipids influenced our 1 H-MRS measurement. We did not find a correlation between the allylic methylene (2.0 ppm) to methylene (1.2 ppm) ratio and serum total cholesterol (Spearman rho ¼ 0.43, p ¼ 0.10) or serum triglycerides (Spearman rho ¼ 0.27, p ¼ 0.31), indicating that serum lipids did not influence our 1 H-MRS spectra. We also assessed whether our 1 H-MRS measurement was influenced by the amount of plaque volume (cholesteryl ester-rich tissue) relative to the perivascular tissue volume (triglyceride-rich tissue). Figure 3 shows that there is a significant correlation between the allylic methylene (2.0 ppm) to methylene (1.2 ppm) ratio and plaque volume to perivascular tissue volume ratio.
Seven subjects were willing to visit us twice, and in these subjects, initial and repeat 1 H-MRS scans were obtained, of whom 4 subjects had analyzable data of both the initial and repeat scan. In this subset of 4 subjects we assessed the agreement between initial and repeat 1 H-MRS scans within patients, and the intraclass correlation coefficient (r) was 0.92 (95% prediction intervals: 0.40 to 0.99), the SD of the paired differences was 0.011, and the reproducibility coefficient was 0.022 (95% limits of agreement: À0.017 to 0.029), for the allylic methylene (2.0 ppm) to methylene (1.2 ppm) ratio, indicating good reproducibility.
D I S C U S S I O N
The present study shows for the first time that image-guided 1 H-MRS of carotid atherosclerotic plaques is feasible in vivo in humans. We successfully quantified the allylic methylene (2.0 ppm) to methylene (1.2 ppm) ratio, which reflects the ratio of the fatty acid composition of plaque cholesteryl ester to that of perivascular tissue triglyceride. Furthermore, the allylic methylene (2.0 ppm) to methylene (1.2 ppm) ratio was shown to have good reproducibility.
1 H-MRS of plaques still has a limited spatial resolution and is technically challenging, illustrated by the fact only 49% of the obtained 1 H-MRS spectra was of adequate quality for analysis. The present data imply that in vivo in humans, 1 H-MRS of carotid artery plaques offers a promising and valuable tool that can specifically identify liquid cholesteryl ester through its specific proton resonances.
The type of lipids and their physical properties in atherosclerotic lesions have been well investigated over the past decades (1). Cholesterol, cholesteryl ester, and phospholipids are known to accumulate in fatty streaks and plaques, whereas triglyceride accumulation does not occur (1) . As early as the 1960s, it was recognized that a large portion of lipids in atherosclerotic lesions accumulate in the form of intracellular droplets. Lang and Insull (9) showed that the droplets contained about one-half of the lipids in the lesions. Furthermore, the composition of the lipids in the droplets was remarkably uniform and comprised 94.9% cholesteryl esters, 1.7% free cholesterol, 1.0% phospholipids, and 2.4% triglycerides. Thus, cholesteryl ester in the liquid phase in intracellular droplets makes up a large portion of the plaque lipid content. Moreover, the reversibility of atherosclerotic lesions likely depends on removal of these liquid cholesteryl esters, in contrast to crystalline cholesterol deposits, which are thought to be trapped within the plaque (1). Therefore, a technique that enables direct and unequivocal identification of cholesteryl ester in the liquid state in plaque can provide important information on plaque phenotype and would enable specific investigation of the effect of antiatherosclerotic interventions aimed at removing cholesteryl esters from plaques.
Based on the findings by Lang and Insull (9), the 1 H-MRS spectra of atherosclerotic plaque are expected to be derived for 95% of cholesteryl esters and for only a small amount of triglycerides (phospholipids are known not to show resonance). The latter contrasts with our observation. Based on the characteristics of the lipid phantoms and our in vivo spectra, we estimate that in addition to cholesteryl ester, the signal from triglycerides does contribute significantly to the in vivo spectra. This apparent discrepancy most likely pertains to the fact that the volume of tissue from which we obtained the in vivo spectra does not only contain plaque, but also a substantial amount of perivascular tissue. Perivascular tissue is known to be composed mainly of adipocytes in which triglyceride droplets are stored (10) . The fatty acyl chains of triglycerides in adipose tissue are 50% comprised of oleate, 12% of linoleate, 25% of palmitic acid, and to a lesser extent, of other fatty acyl chains (11) . In contrast, the fatty acyl chains of the cholesteryl esters in plaques comprise w35% oleate, 35% linoleate, 14% palmitic acid, and to a lesser extent other fatty acyl chains (12) . Oleate (the carbon-to-double bond ratio of 18:1) consists of a single allylic methylene (CH 2 -CH¼CH-CH 2 ) and 14 methylenes (CH 2 ). Linoleate (18:2) consists of 2 allylic methylenes and 12 methylenes. Palmitic acid (16:0) has 14 methylenes but does not have an allylic methylene group. The markedly different composition of fatty acyl chains of plaque cholesteryl ester and perivascular triglycerides results in a lower allylic methylene-to-methylene ratio in perivascular triglycerides as opposed to plaque cholesteryl ester.
The contribution of serum lipids to the spectra is minimal. We estimate that in the lumen volume included in the 1 H-MRS voxel, the amount of lipids approximates 0.5 mg total serum cholesterol and 0.3 mg serum triglycerides. This is negligible compared with the amount of cholesteryl ester in plaques, which exceed an order of magnitude of 4 to 28 mg (9) . Therefore, we expect the impact of serum lipids on the 1 H-MRS spectra to be minimal. Furthermore, we did not find a relationship between serum lipid levels and the allylic methylene (2.0 ppm) to methylene (1.2 ppm) ratio.
MRS studies of ex vivo atherosclerotic lesions have been performed with both 13 C-MRS and 1 H-MRS (4-7,13-16). 13 C-MRS studies showed that the spectra obtained from plaque reflect almost exclusively cholesteryl ester in the liquid state (13) (14) (15) (16) . Lipids in liquid crystalline and crystalline phases, such as phospholipids and cholesterol were detected by magic angle spinning voxels, localized to plaque regions that were either lipid rich or lipid poor and showed that the spectra from lipid-rich areas showed much more intense cholesteryl ester resonances than did lipid-poor regions. Our in vivo findings corroborate the previous ex vivo 1 H-MRS studies, as our data also showed typical spectra of mixed cholesteryl ester and triglyceride, with resonance from the methyl (0.8 ppm), methylene (1.2 ppm), and allylic methylene (2.0 ppm) protons. Furthermore, Ruberg et al. (7) also performed 1 H-MRS on lipid standards of pure cholesteryl ester, pure triglycerides, and pure phospholipids and showed identical proton spectra compared with our pure cholesteryl ester, pure triglyceride spectra. No resonances from the phospholipids were observed, which was expected because of their highly restricted and anisotropic motion in the liquid crystalline multilayer. Study limitations. First, with our image-guided 1 H-MRS approach, spectra were obtained of a volume that contained blood in the lumen of the vessel, plaque tissue, and perivascular tissue. Due to limited resolution and the point spread function of the chemical shift imaging sequence, the proton spectra could not be obtained of only plaque tissue. Nonetheless, plaque tissue is known to have abundant cholesteryl ester content and very little triglycerides, whereas the opposite is true for perivascular tissue. Thus, the contribution of the fatty acids of cholesteryl ester to the signal is likely to be derived specifically from plaque tissue. Second, the 1 H-MRS spectra do not permit an absolute quantification of the amount of cholesteryl ester to be determined. Instead 1 H-MRS spectra provide the amount of cholesteryl ester in relation to the amount of triglycerides. Because this relies on the amount of plaque tissue and perivascular tissue included in the volume from which the spectrum is obtained, comparison between subjects is cumbersome. Nonetheless, our current approach is suitable for longitudinal comparison within subjects, as long as the volume from which the 1 H-MRS spectrum is obtained is located in the same location. The fact that our measurement showed good reproducibility shows that reproducible localization of imageguided 1 H-MRS is feasible. The third limitation is that it proved to be difficult to obtain good quality 1 H-MRS spectra. About one-half of the spectra were of poor quality. This could be due to various factors, such as separating the signal of methylene and allylic methylene protons, unmet shimming requirements, signal loss due to the deep localization of the carotid arteries, and patient movement. For future studies we need to optimize the 1 H-MRS methods to improve the quality of the spectra.
C O N C L U S I O N S
The present study shows for the first time that image-guided 1 H-MRS of carotid atherosclerotic plaques is feasible in vivo in humans and can possibly detect cholesteryl ester in the liquid phase. The ratio of the resonance of the allylic methylene (2.0 ppm) to methylene (1.2 ppm) protons reflects the fatty acid composition of plaque cholesteryl ester relative to that of perivascular triglycerides in the scanned volume. Our image-guided 1 H-MRS method showed good reproducibility. Future studies are needed to further address the limitations of the technique, improve the quality of the 1 H-MRS spectra, and enable quantification of liquid-phase cholesteryl ester.
